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ABSTRACT
Objective: We evaluated the role of MRI as a preoperative
diagnostic tool for leiomyoma and adenomyosis.
Method: This is a retrospective chart review at a univer-
sity-based hospital. The study included 1517 women who
underwent hysterectomy or myomectomy over a 5-year
period, and 153 women with a preoperative pelvic MRI
were included. Comparisons were made between the re-
sults of the MRI and postoperative pathology reports.
Results: The MRI and pathology report were the same for
136 of 144 women with leiomyoma and 12 of 31 women
with adenomyosis. The MRI had 94% sensitivity and 33%
specificity for leiomyoma and 38% sensitivity and 91%
specificity for adenomyosis. Positive and negative predic-
tive values of MRI for leiomyoma were 95% and 27% with
90% accuracy. Positive and negative predictive values of
MRI for adenomyosis were 52% and 85%, respectively,
with 80% accuracy.
Conclusion: MRI has a high sensitivity and a low speci-
ficity for diagnosing leiomyoma and a high specificity and
a low sensitivity for diagnosing adenomyosis. Due to the
high cost and technical variations, we suggest using MRI
only as an adjunctive diagnostic tool when ultrasound is
not conclusive and differentiation between the 2 pathol-
ogies ultimately affects patient management.
Key Words: Leiomyoma, Adenomyosis, MRI (Magnetic
Resonance Image), Pelvic Ultrasound.
INTRODUCTION
Uterine leiomyomas and adenomyosis are 2 common pel-
vic pathologies in women of reproductive age. They may
have similar presentations but possibly different treatment
modalities, ie, hysterectomy for adenomyosis versus con-
servative management or hysterectomy for leiomyomas,
or both. However, only limited studies have been per-
formed on the efficacy of conservative treatment of ade-
nomyosis, and these typically do not improve or preserve
fertility.1–4
Thus, preoperative diagnosis becomes important in coun-
seling patients appropriately regarding treatment options.
Currently, ultrasound is used as the first diagnostic tool to
evaluate pelvic pathology. MRI provides better tissue con-
trast and may be superior to other imaging modalities in
certain pelvic pathologies, such as congenital uterine
anomalies, leiomyoma, adenomyosis, and endometrio-
mas.5–10 Some reports suggest MRI is a reliable preopera-
tive tool available to physicians to assist in differentiating
between fibroids and adenomyoma/adenomyosis.11–14 In
this study, we evaluated the predictive value of the pre-
operative MRI in differentiating between leiomyoma and
adenomyosis compared with pathologic findings.
METHODS
A 5-year retrospective chart review was performed from
January 1999 to December 2004 in a university-based
hospital among patients who were admitted to undergo
hysterectomy, myomectomy, or both. IRB approval was
obtained. Although 1517 charts were reviewed, only 153
patients who underwent a preoperative MRI were selected
for this study.
Patients ranged in age from 21 to 69 with a mean age of 41
and a median age of 39. The presenting symptoms were as
follows: 73(48%) had menorrhagia, 34(22%) had dysmen-
orrhea, 31(20%) had pelvic pain, 40(26%) had a pelvic
mass, 16(10%) had irregular bleeding, 14(9%) had infer-
tility, and 2(1.3%) had postmenopausal bleeding.
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SCIENTIFIC PAPEROf these patients, 50 had a hysterectomy and the other 103
had a myomectomy. Pathology reports of surgical speci-
mens were compared with the results of preoperative MRI
studies.
MRI Studies
MRI studies were performed in axial, sagittal, and coronal
planes with various T1-weighted spin-echo and T2-
weighted turbo spin-echo or spin-echo on a 1.5 Tesla
system (GYRO scan, Phillips Medical Systems, Bothell,
Washington, USA or GE open magnet MRI scanners, Gen-
eral Electric Company, Fairfield, Connecticut, USA) in dif-
ferent centers. Contrast enhanced gadolinium was used as
an additive technique in 50 cases to achieve better tissue
contrast in the patients suspicious for leiomyoma. Leiomy-
oma appeared as low-signal intensity in T2-weighted im-
ages and intermediate- to high-signal intensity in T1-
weighted images.
Adenomyosis was described as a focal or diffuse widening
of junctional zone above 12 mm, uterine enlargement, or
both, with focal or diffuse low-signal intensity myometrial
area in T2-weighted images. Also on contrast enhanced
T1-weighted images, (gadolinium scan) small hypoin-
tense myometrial spots were indicative of adenomyosis.
MRI interpretation was performed by different observers
in different centers including private radiology centers,
community and university hospitals.
RESULTS
Different pathologists in the pathology department at
Stanford University Medical Center examined surgical
specimens. The results were used to confirm the MRI
findings for the presence of leiomyoma and adenomyosis.
According to the pathology reports, 120 had only leiomy-
oma, 23 had leiomyoma with coexisting adenomyosis,
and 9 had adenomyosis. One patient in the hysterectomy
group had a normal MRI and pathology report that re-
vealed no myoma or adenomyosis. She was also included
in the study. Fifteen patients had other pelvic pathologies
coexisting with leiomyoma or adenomyosis, or coexisting
with both.
MRI studies correctly diagnosed 136 of 144 patients with
leiomyoma. In the remaining 8 patients with leiomyoma,
MRI missed the diagnosis. MRI revealed leiomyoma in 6
patients without disease. Only 3 patients without disease
had a negative MRI. Data analyses were as follows: sen-
sitivity 94%, specificity 33%, positive predictive value 95%,
and negative predictive value 27%.
For adenomyosis, in 31 patients, MRI revealed true posi-
tive, false-positive, and false-negative results in 12, 11, and
19 patients, respectively. MRI studies revealed the correct
diagnoses in all 111without adenomyosis.
The positive and negative predictive values of MRI for
adenomyosis were 52%, 85%, respectively, with 38% sen-
sitivity and 91% specificity.
As mentioned previously, 23 cases had coexisting leiomy-
oma and adenomyosis. MRI revealed correct diagnoses in
only 9/23 patients, in 12/23 it revealed only myoma, and
in 2/23 it diagnosed only adenomyosis. Sensitivity for the
diagnosis of both disease entities was only 39%.
DISCUSSION
Adenomyosis and leiomyoma are 2 benign uterine condi-
tions with similar clinical presentations and different
pathogeneses. Adenomyosis or internal endometriosis is a
disease of parous women with the peak incidence be-
tween 40 to 50 years of age.15,16 It is characterized by the
presence of endometrial glands and stroma inside the
uterine myometrium.17 According to different histological
interpretations of the hysterectomy specimens, frequency
of adenomyosis may vary from 20% to as high as 65%
among parous women.18–20
Uterine involvement may be focal or diffuse, and the size
of the lesion ranges from a gross macroscopic well-de-
fined lesion (adenomyoma that mimics myoma) to a mi-
croscopic lesion. Uterine leiomyoma is a benign smooth
muscle tumor with 25% prevalence in women of repro-
ductive age with a predominance among African Ameri-
can women.21–23 Furthermore, pathology examination of
surgical specimens revealed an incidence of leiomyoma as
high as 77%.24
The clinical presentation can be similar between the 2
disease entities. The most common symptom is abnormal
uterine bleeding25 with a predominance of menorrhagia.
Dysmenorrhea, another common symptom, occurs in 25%
of patients.26
A definitive diagnosis for both categories is possible based
on histological examination of surgical specimens, but
imaging techniques are increasingly used for preoperative
evaluation and diagnosis.
Transvaginal ultrasound and pelvic MRI are increasingly
used as a preoperative diagnostic tool for adenomyosis.27
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almost the same sensitivity (68% versus 70%), the speci-
ficity is greater for MRI (86% versus 65%).11,28–30
Pelvic MRI is also used in the diagnosis of leiomyoma
when a patient’s obesity or extreme uterine retroversion,
or both, hinder pelvic ultrasound performance. It is also
useful in preoperative localization of uterine leiomyoma.31
Pelvic MRI is highly specific in the diagnosis of adenomy-
osis (91%) and highly sensitive for leiomyoma (94%) ac-
cording to our findings.
Currently, pelvic ultrasound, a relatively affordable and
effective method, is widely used as an office procedure in
the diagnosis of leiomyoma. It is more efficacious to limit
the use of MRI for specific conditions when uterine pres-
ervation is the goal of therapy, such as localization of
leiomyoma in an infertile patient or when the patient is a
candidate for uterine artery embolization.
Our results are different from the results in previously
published reports that indicated a higher sensitivity (70%
vs. 38%) of MRI for adenomyosis11,28–30 and higher spec-
ificity (100% vs. 33%) for leiomyoma.32 This can possibly
be explained because our study was influenced by selec-
tion bias. Because the study was performed on a diseased
population with a previous diagnosis of myoma or ade-
nomyosis, or both, where ultrasound alone was thought
by the physician to be inadequate. Therefore, there were
very few patients in our study with negative findings,
leading to a low specificity. However, it was not possible
to select another population, because of the retrospective
nature of the study.
Also, MRI studies were done in different centers and
interpreted by different radiologists, which may produce
interobserver bias. Like other radiological studies, MRI is
highly operator dependent, and the results may be influ-
enced by technical and observer interpretation. Further-
more, different pathologists examined the surgical speci-
mens. However, this may be a strength of the study in the
sense that in reality there will not always be the same
specialist reviewing all the studies.
Of 153 patients who had MRI as a preoperative diagnostic
tool, 103 underwent myomectomies, so there may be an
inherent bias against identifying false-negative adenomy-
osis.
CONCLUSION
At the present time, pelvic ultrasound is used as a first line
for the diagnosis of uterine pathology.2 MRI is used less
frequently than ultrasound due to cost and technical vari-
ations. However, it may be helpful for diagnosis of pelvic
pathologies that are not well defined with ultrasound
studies.
We suggest MRI be used as a complementary diagnostic
tool in patients whose ultrasound examination does not
clarify the diagnosis, such as in extreme uterine retrover-
sion or obesity, or both, and in patients whose ultrasound
examination is indicative of adenomyosis and there is a
desire for conservative management.
MRI has high specificity and negative predictive value for
adenomyosis. If the preoperative MRI shows no adeno-
myosis, patients can be counseled of the low likelihood of
having adenomyosis (15%) and therefore conservative
management can be offered.
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